Microbiological characterisation of Burkholderia cepacia isolates from cystic fibrosis patients: Investigation of the exopolysaccharides produced

FEMS Microbiology Letters

Volumn 209, Issue 1, 2002, Pages 99-106

  Lagatolla, Cristina ^a   Skerlavaj, Silvia ^a   Dolzani, Lucilla ^a   Tonin, Enrico A ^a   Monti Bragadin, Carlo ^a   Bosco, Marco ^b   Rizzo, Roberto ^a   Giglio, Luisella ^c   Cescutti, Paola ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b Area di Ricerca   (Italy)

^c INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Burkholderia cepacia; Cystic fibrosis; Exopolysaccharide; Genomovar; Random amplification of polymorphic DNA; Ribotyping

Indexed keywords

BACTERIAL DNA; BACTERIAL POLYSACCHARIDE; EXOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BURKHOLDERIA CEPACIA; CARBOHYDRATE ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYSTIC FIBROSIS; DNA DETERMINATION; GENE AMPLIFICATION; HUMAN; METHYLATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RIBOTYPING; SPUTUM; STRAIN DIFFERENCE; STRUCTURE ANALYSIS; VAGINA SMEAR;

BURKHOLDERIA; BURKHOLDERIA CEPACIA;

EID: 0037133746     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1574-6968.2002.tb11116.x     Document Type: Article

References (19)

1. Burkholderia cepacia: Medical, taxonomic an ecological issues
2. Marked phenotypic variability in Pseudomonas cepacia isolated from a patient with cystic fibrosis
3. Identification of Burkholderia spp. in the clinical microbiology laboratory comparison of conventional and molecular methods
4. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates
5. DNA-based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III
6. Structural elucidation of a novel exopolysaccharide produced by a mucoid clinical isolate of Burkholderia cepacia. Characterization of a trisubstituted glucuronic acid residue in a heptasaccharide repeating unit
7. Exopolysaccharide production by mucoid and non-mucoid strains of Burkholderia cepacia
8. Structural study of the exopolysaccharide produced by a clinical isolate of Burkholderia cepacia
9. Structural studies of the acidic exopolysaccharide produced by a mucoid strain of Burkholderia cepacia isolated from cystic fibrosis
10. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium
11. Identification of Acinetobacter isolates in the A. calcoaceticus-A. baumannii complex by restriction analysis of the 16S-23S rRNA intergenic spacer sequences
12. Detection of Pseudomonas (Burkholderia) cepacia using PCR
13. Discrimination of Burkholderia gladioli from other Burkholderia species detectable in cystic fibrosis patients by PCR
14. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: Analysis by randomly amplified polymorphic DNA fingerprinting
15. Ribotyping of the Acinetobacter calcoaceticus-Acinetobacter baumanni complex
16. Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems
17. Hexose phospate metabolism and exopolysaccharide formation in Pseudomonas cepacia
18. Structures of the two polymers present in the lipopolysaccharide of Burkholderia (Pseudomonas) cepacia serogroup O4
19. Fractionation by precipitation with quaternary ammonium salts